Modeling the Epstein-Barr Virus Latency Switch in Human B-Cells
Author Information
Author(s): Wern Maria, Ernberg Ingemar, Zou JieZhi, Almqvist Jenny, Aurell Erik
Primary Institution: Royal Institute of Technology, Karolinska Institute
Hypothesis
The genetic switch between viral latency programs is controlled by both human and viral transcription factors; Oct-2 and EBNA-1.
Conclusion
The study demonstrates that EBNA-1 and Oct-2 regulation of viral promoters can establish mutually exclusive expression patterns, with implications for understanding tumor biology.
Supporting Evidence
- Experimental results show significant differences in EBNA-1 and Oct-2 levels between resting and proliferating programs.
- The model predicts mutually exclusive promoter activities in the two different latency programs.
- Transitions between latency states can be induced by altering transcription factor levels.
Takeaway
This study shows how a virus can switch between two states in human cells, which can help us understand how it might cause diseases like cancer.
Methodology
A physico-chemical model was constructed to investigate the dynamics of promoter regulation and protein level variations between latency programs.
Limitations
The model simplifies the complex in vivo mechanisms and does not account for all regulatory factors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website